Bill number does not exist. Enter a vaild keyword.
Original
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Opposite
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Review in
Original Chamber
Passed Both
Chambers
Conf. Cmte
(if necessary)
To Governor
Title
Prescription Drug Monitoring Program - Prescribers of Opioids - Notification Requirement
Sponsored by
Delegates Beitzel and McComas
Status
In the House - Hearing 3/03 at 1:30 p.m.
Analysis
Fiscal and Policy Note
Synopsis
Requiring a prescriber to notify the Prescription Drug Monitoring Program as to whether the prescriber has received education regarding the risks of opioid use, is aware that an opioid overdose reversal drug is available, and has prescribed or dispensed an opioid overdose reversal drug if the prescriber prescribes or dispenses an opioid in a dosage of 50 morphine milligram equivalents or more; and prohibiting a prescriber from being required to make the notification more than once for each patient.
Committee Testimony
Details
Introduced in a prior session as: HB1125 Session: 2021 Regular Session
Bill File Type: Regular
Effective Date(s): October 1, 2022
Legislation History
Chamber
House
Calendar Date
2/11/2022
Legislative Date
2/11/2022
Action
First Reading Health and Government Operations
Proceedings
Chamber
House
Calendar Date
2/14/2022
Legislative Date
2/14/2022
Action
Hearing 3/03 at 1:30 p.m.
Proceedings
Chamber Calendar Date Legislative Date Action Proceedings
House 2/11/2022 2/11/2022 First Reading Health and Government Operations
Text - First - Prescription Drug Monitoring Program - Prescribers of Opioids - Notification Requirement
House 2/14/2022 2/14/2022 Hearing 3/03 at 1:30 p.m.
Last Updated: 7/8/2022 2:34 PM
Click to return on the top page